SYNAPTICS Inc
For the period ended Sep 28, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 28, 2024 · Filed Nov 7, 2024
SYNA$117.70+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows—
(in millions)
| Three Months Ended | ||
|---|---|---|
| September | ||
| 2024 | 2023 | |
| Cash flows from operating activities | ||
| Net loss | $(23.1) | $(55.6) |
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||
| Share-based compensation costs | 27.2 | 33.2 |
| Depreciation and amortization | 7.2 | 7.2 |
| Acquired intangibles amortization | 24.6 | 23.3 |
| Deferred taxes | (15.0) | (1.1) |
| Other | 3.5 | 12.6 |
| Changes in operating assets and liabilities, net of acquisitions: | ||
| Accounts receivable, net | 6.6 | 53.6 |
| Inventories, net | (4.6) | (6.8) |
| Prepaid expenses and other current assets | (1.9) | (4.8) |
| Other assets | 3.4 | 0.9 |
| Accounts payable | (6.3) | 16.7 |
| Accrued compensation | 0.7 | (22.0) |
| Other accrued liabilities | (33.7) | (11.8) |
| Net cash (used in) provided by operating activities | (11.4) | 45.4 |
| Cash flows from investing activities | ||
| Proceeds from maturity of investments | — | 3.2 |
| Purchases of short-term investments | — | (16.6) |
| Purchases of property and equipment | (9.1) | (6.7) |
| Purchase of intangible assets | — | (13.5) |
| Advance payment on intangible assets | — | (116.5) |
| Net cash used in investing activities | (9.1) | (150.1) |
| Cash flows from financing activities | ||
| Proceeds from issuance of shares | 7.7 | 8.5 |
| Payroll taxes related to net share settlement of share-based awards | (11.3) | (25.3) |
| Repayment of debt | (1.5) | (3.0) |
| Other | 1.6 | 1.7 |
| Net cash used in financing activities | (3.5) | (18.1) |
| Effect of exchange rate changes on cash and cash equivalents | 0.7 | (0.6) |
| Net decrease in cash and cash equivalents | (23.3) | (123.4) |
| Cash and cash equivalents, beginning of period | 876.9 | 924.7 |
| Cash and cash equivalents, end of period | $853.6 | $801.3 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.